Wang Xiaowei – Trademark Portfolio
Entity Type: 01
Wang Xiaowei holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 20 (Furniture) — 7 filings in this category. The portfolio also extends into Class 28 (Toys & Sporting Goods) across 7 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include ASPOT, CEMULA, GRWANG, ROYPET, and BESSOME. The owner is based in HangZhou, ZheJiang.
No.176, QiuTao North Rd
HangZhou, ZheJiang 310020 , CN
Showing of trademarks Trademarks
Trademark Classifications
Wang Xiaowei's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Wang Xiaowei have?
Wang Xiaowei has 14 U.S. trademarks filed with the USPTO. Of these, 7 registered, 5 abandoned, 2 cancelled.
What trademark classes does Wang Xiaowei file in?
Wang Xiaowei files trademarks across 7 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 28 (Toys & Sporting Goods), Class 9 (Computers & Electronics), Class 18 (Leather Goods), Class 15 (Musical Instruments). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.
What are Wang Xiaowei's most well-known trademarks?
Wang Xiaowei's registered trademark portfolio includes well-known marks such as ASPOT, CEMULA, GRWANG, ROYPET, and BESSOME. These are among 7 currently registered trademarks in the portfolio.
What is Wang Xiaowei's trademark registration success rate?
Wang Xiaowei has a 50% trademark registration rate, with 7 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.